Tracked deals
3
3 tracked deals across 2017-2021.
Amsterdam, Noord-Holland, Netherlands
Over the past decade we have transformed into a focused leader in health technology. At Philips, our purpose is to improve people’s health and well-being through meaningful innovation—supporting clinicians and patient care via connected healthcare solutions, including diagnostic and patient monitoring technologies and healthcare informatics.
Tracked deals
3
3 tracked deals across 2017-2021.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout
Last 2 years
Supporting Data
Royal Philips has signed an agreement to acquire Vesper Medical Inc., a US-based maker of minimally-invasive peripheral venous stent devices and a portfolio company of Gilde Healthcare. The acquisition will add Vesper's DUO Venous Stent System to Philips' image-guided therapy and peripheral vascular portfolio; the deal is expected to close in Q1 2022 and includes roughly 20 Vesper employees joining Philips.
Royal Philips agreed to acquire Capsule Technologies, a portfolio company of Francisco Partners, for $635 million in cash. The deal will fold Capsule — a developer of medical device integration, patient monitoring, and clinical surveillance software used by hospitals worldwide — into Philips' Connected Care segment; Capsule has roughly 300 employees and serves more than 2,800 hospitals in 40 countries.
Royal Philips has acquired US-based startup Analytical Informatics, Inc. to integrate the company's vendor-agnostic radiology workflow and analytics tools into Philips' PerformanceBridge radiology portfolio. The acquisition is intended to accelerate Philips' roadmap for Radiology Solutions by expanding operational intelligence, workflow optimization and data-driven decision support for imaging departments and enterprise customers; financial terms were not disclosed.
Turn tracked acquisition activity into an outreach-ready buyer list.